4th Annual MCLE-a-thon: Federal Funding & Legal Landmines: A Guide for In‑House Teams
As part of the firm’s 4th annual MCLE‑a‑thon, Lance D. Smemoe provides a practical overview of the intellectual property risks associated with federal funding and government contracts. Lance discusses how...
Amendments to Mexico’s Federal Law for Protection of Industrial Property Inform More Flexible International IP Strategy for Biotech Companies
Key Takeaway: Amendments to Mexico’s Federal Law for Protection of Industrial Property align more with U.S. Patent and Trademark Office standards for restoring priority and application revival, increasing international patent...
When “About” Becomes Indefinite: Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v. Safe Foods
Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance, “about” may...